Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 201–300 of 1,004
Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases
Ren, J., & Zhang, Y. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.005 · Cited by 268
“S6K1−/−mice Global aging and high fat diet protects against obesity due to enhanced beta-oxidation, sensitive to insulin owing to loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation [86]”
BackgroundEmerging Roles for the Lysosome in Lipid Metabolism
Thelen, A. M., & Zoncu, R. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.006 · Cited by 266
Öst, A., Svensson, K., Ruishalme, I., Brännmark, C., Franck, N., Krook, H., Sandström, P., Kjolhede, P., & Strålfors, P. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00023 · Cited by 270
Pearce, L. R., Alton, G. R., Richter, D. T., Kath, J. C., Lingardo, L., Chapman, J., Hwang, C., & Alessi, D. R. (2010) · Biochemical Journal · doi:10.1042/bj20101024 · Cited by 265
Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty
Stout, M. B., Justice, J. N., Nicklas, B. J., & Kirkland, J. L. (2017) · Physiology · doi:10.1152/physiol.00012.2016 · Cited by 272
Macotela, Y., Emanuelli, B., Bång, A. M., Espinoza, D. O., Boucher, J., Beebe, K., Gall, W., & Kahn, C. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021187 · Cited by 263
“…HFD + Leu mice compared to HFD mice, which in vitro results in increased serine phosphorylation and decreased tyrosine phosphorylation of IRS-1 [25–27], the increased serine phosphorylation of IRS-1 in vivo produced by leucine supplementation is associated with improved insulin signaling and…”
Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 254
Self-citationEmerging role of autophagy in kidney function, diseases and aging
Huber, T. B., Edelstein, C. L., Hartleben, B., Inoki, K., Jiang, M., Koya, D., Kume, S., Lieberthal, W., Pallet, N., Quiroga, A., et al. (2012) · Autophagy · doi:10.4161/auto.19821 · Cited by 253
Obesity May Accelerate the Aging Process
Salvestrini, V., Sell, C., & Lorenzini, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00266 · Cited by 260
“Decreased activation of mTOR/S6K1 has been associated with increased insulin sensitivity (104).”
BackgroundInfluentialLeucine nutrition in animals and humans: mTOR signaling and beyond
Li, F., Yin, Y., Tan, B., Kong, X., & Wu, G. (2011) · Amino Acids · doi:10.1007/s00726-011-0983-2 · Cited by 249
“By activating mTOR and S6K1, leucine feedback inhibits insulin signaling and decrease glucose utilization in skeletal muscle (Patti et al. 1998; Tremblay and Marette 2001; Krebs et al. 2002; Um et al. 2004).”
BackgroundImpact of Diet Composition on Blood Glucose Regulation
Russell, W. R., Baka, A., Björck, I., Delzenne, N., Gao, D., Griffiths, H. R., Hadjilucas, E., Juvonen, K., Lahtinen, S., Lansink, M., et al. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.792772 · Cited by 255
PI(3)King Apart PTEN's Role in Cancer
Zhang, S., & Yu, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2990 · Cited by 248
“Inhibition of mTOR could release this inhibition and trigger a positive feedback to reactivate PI3K signaling (50).”
BackgroundSignalling and autophagy regulation in health, aging and disease
Meijer, A. J., & Codogno, P. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.002 · Cited by 244
“There are now strong indications that overactivation of amino acid-dependent mTOR-mediated signalling leads to the inhibition of the proximal part of the insulin signalling pathway (Um et al., 2004; Khamzina et al., 2005) (Fig.”
BackgroundThe S6K protein family in health and disease
Tavares, M. R., Pavan, I. C. B., Amaral, C. L., Meneguello, L., Luchessi, A. D., & Simabuco, F. M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.001 · Cited by 235
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100443 · Cited by 251
“As an example, mTOR/S6K overactivation causes insulin and GF resistance [100-104].”
BackgroundSchwartz, S., Wongvipat, J., Trigwell, C. B., Hancox, U., Carver, B. S., Rodrik-Outmezguine, V., Will, M., Yellen, P., de Stanchina, E., Baselga, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.008 · Cited by 246
Natural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats
Lloberas, N., Cruzado, J. M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., Rama, I., Vidal, A., & Grinyó, J. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050549 · Cited by 245
“(33) showed that absence of S6K1, an effector pathway of mTOR, protects against age- and diet-induced obesity in mice; this offers a potential explanation for the consistent effect of SRL on weight gain.”
BackgroundProtein kinase signaling networks in cancer
Brognard, J., & Hunter, T. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.012 · Cited by 240
“These factors must be taken into consideration when targeting various components of this pathway, since feedback loops are used to temper signaling through this pathway [44–46].”
Atf4 Regulates Obesity, Glucose Homeostasis, and Energy Expenditure
Seo, J., Fortuno, E. S., Suh, J. M., Stenesen, D., Tang, W., Parks, E. J., Adams, C. M., Townes, T., & Graff, J. M. (2009) · Diabetes · doi:10.2337/db09-0335 · Cited by 243
“Similarly, strains of 4E-BP1 mutant mice and S6K mutant mice are lean and have increased energy expenditure (9,10).”
BackgroundChakrabarti, P., English, T., Shi, J., Smas, C. M., & Kandror, K. V. (2010) · Diabetes · doi:10.2337/db09-1602 · Cited by 227
“Thus, in mice, genetic ablation of the mTORC1 substrate, S6K1, produces lean phenotype with elevated levels of free fatty acids in the blood under high-fat diet, suggesting that S6K1 may have an antilipolytic effect (5,6).”
BackgroundInsulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 225
β-adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure
Collins, S. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00102 · Cited by 221
“Some of these genes include p70 S6 kinase (Um et al., 2004), estrogen related receptor-α (Luo et al., 2003), co-repressor RIP140 (Leonardsson et al., 2004), the liver X receptors (LXR; Kalaany et al., 2005), and others (Dong et al., 2009; Gao et al., 2009).”
BackgroundTeutonico, A., Schena, P. F., & Di Paolo, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050487 · Cited by 239
Healthful aging mediated by inhibition of oxidative stress
Vatner, S. F., Zhang, J., Oydanich, M., Berkman, T., Naftalovich, R., & Vatner, D. E. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101194 · Cited by 238
Jastrzebski, K., Hannan, K. M., Tchoubrieva, E. B., Hannan, R. D., & Pearson, R. B. (2007) · Growth Factors · doi:10.1080/08977190701779101 · Cited by 240
“As such, these animals show reduced S312, S636/639 and S1101 phosphorylation of IRS-1, which are otherwise markedly induced in mouse models of obesity thus demonstrating a direct link between S6K1 activation and metabolic disorders (Um et al. 2004; Tremblay et al. 2007).”
BackgroundResultInfluentialExploring Disease through Metabolomics
Vinayavekhin, N., Homan, E. A., & Saghatelian, A. (2010) · ACS Chemical Biology · doi:10.1021/cb900271r · Cited by 230
Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611214200 · Cited by 236
Metabolic transformation in cancer
Tennant, D. A., Duran, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 225
Insulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233
“One study conducted in mice deficient in S6K1 demonstrated that mice were protected against insulin resistance under high-fat diet (HFD) conditions, which was apparent in the loss of negative regulation from S6K1 through its serine phosphorylation of IRS1 [86,87].”
BackgroundWang, W., Nag, S., Zhang, X., Wang, M., Wang, H., Zhou, J., & Zhang, R. (2015) · Medicinal Research Reviews · doi:10.1002/med.21327 · Cited by 224
The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. (2007) · Diabetes · doi:10.2337/db06-1016 · Cited by 230
“Recent reports indicate that the activity of the mTOR pathway is increased in rodent models of obesity and that mice deficient in S6 kinase (S6K), a downstream effector of mTOR, are protected against diet-induced insulin resistance (20,21).”
BackgroundMethodPazienza, V., Clément, S., Pugnale, P., Conzelman, S., Foti, M., Mangia, A., & Negro, F. (2007) · Hepatology · doi:10.1002/hep.21634 · Cited by 227
PTEN signaling in brain: neuropathology and tumorigenesis
Endersby, R., & Baker, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.239 · Cited by 222
Multiple amino acid sensing inputs to mTORC1
Shimobayashi, M., & Hall, M. N. (2016) · Cell Research · doi:10.1038/cr.2015.146 · Cited by 223
Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed
Hartford, C. M., & Ratain, M. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100317 · Cited by 228
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
Regulation of mTORC2 Signaling
Fu, W., & Hall, M. N. (2020) · Genes · doi:10.3390/genes11091045 · Cited by 213
Role of AMP‐activated protein kinase in the metabolic syndrome and in heart disease
Hardie, D. G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.018 · Cited by 217
Peng, M., Yin, N., & Li, M. O. (2014) · Cell · doi:10.1016/j.cell.2014.08.038 · Cited by 220
Sunayama, J., Matsuda, K.-I., Sato, A., Tachibana, K., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., Kayama, T., Tomiyama, A., et al. (2010) · Stem Cells · doi:10.1002/stem.521 · Cited by 218
Metabolic networks of longevity
Houtkooper, R. H., Williams, R. W., & Auwerx, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.029 · Cited by 217
“These mice are lean and sensitized to insulin because of a decrease in the phosphorylation of threonine residues in IRS1 (insulin receptor substrate 1) resulting in altered insulin signaling (Um et al., 2004).”
BackgroundSelf-citationRachdi, L., Balcazar, N., Osorio-Duque, F., Elghazi, L., Weiss, A., Gould, A., Chang-Chen, K. J., Gambello, M. J., & Bernal-Mizrachi, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803047105 · Cited by 209
Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate
Gan, X., Wang, J., Su, B., & Wu, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195016 · Cited by 209
“The mTORC1 activity is sensitive to inhibition by rapamycin, which regulates diverse cellular processes, including protein synthesis, ribosome biogenesis, transcription and autophagy, some of which are regulated through its direct substrates S6 kinases (S6K) and the eIF-4E binding protein 1 [13-16].”
BackgroundThe amino acid sensitive TOR pathway from yeast to mammals
Dann, S. G., & Thomas, G. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.068 · Cited by 213
“The importance of the nutrient branch of the mTOR signaling pathway is underscored by recent studies showing that nutrient overload, while driving cell growth, also acts to suppress insulin signaling, leading to hyperglycemia and insulin resistance [36,38].”
BackgroundSelf-citation‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
“Further, lifespan is also extended: (i) in fat cell insulin receptor, insulin receptor substrate-1 and S6 kinase-1 deficient (knockout) mice (each of which has limited fat development; Bluher et al. 2003; Um et al. 2004; Selman et al. 2008; Selman et al. 2009); (ii) in growth hormone receptor knockout (GHRKO) mice (wh…”
BackgroundHaas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 210
“, 1999) and its downstream targets mTORC1 (Um et al., 2004; Khamzina et al., 2005), as well as PKC-l (Standaert et al.”
Autophagy: Regulation and role in disease
Meijer, A. J., & Codogno, P. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360903044068 · Cited by 199
Growth and aging: a common molecular mechanism
Blagosklonny, M. V., & Hall, M. N. (2009) · Aging · doi:10.18632/aging.100040 · Cited by 212
“S6K are protected against age- and diet-induced obesity [25, 26].”
BackgroundS6K1 Plays a Critical Role in Early Adipocyte Differentiation
Carnevalli, L. S., Masuda, K., Frigerio, F., Le Bacquer, O., Um, S. H., Gandin, V., Topisirovic, I., Sonenberg, N., Thomas, G., & Kozma, S. C. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.018 · Cited by 204
Self-citationMetformin: A Therapeutic Opportunity in Breast Cancer
Gonzalez-Angulo, A. M., & Meric-Bernstam, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1805 · Cited by 209
Wang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., & Liu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700098200 · Cited by 210
Supplementing l-leucine to a low-protein diet increases tissue protein synthesis in weanling pigs
Yin, Y., Yao, K., Liu, Z., Gong, M., Ruan, Z., Deng, D., Tan, B., Liu, Z., & Wu, G. (2010) · Amino Acids · doi:10.1007/s00726-010-0612-5 · Cited by 206
“S6K1 phosphorylates ribosomal protein S6 and promotes the translation of mRNA containing a TOP motif (Um et al. 2004).”
PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
Willems, L., Tamburini, J., Chapuis, N., Lacombe, C., Mayeux, P., & Bouscary, D. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0227-y · Cited by 201
“Although the activation of mTORC1 may be independent of PI3K in some tumors, both signaling networks remain subject to complex crosstalk and feedback interactions in normal and in cancer cells: the phosphorylated P70S6K protein downstream of mTORC1 exerts negative feedback on insulin and insulin-like growth factor 1 (…”
BackgroundThe coordination of nuclear and mitochondrial communication during aging and calorie restriction
Finley, L. W. S., & Haigis, M. C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.003 · Cited by 207
“Compared to wild type counterparts, mice deficient for S6K1 have higher expression of genes involved in OXPHOS and fatty acid oxidation in both white adipose tissue and skeletal muscle (Um et al., 2004).”
BackgroundPTEN in cancer, metabolism, and aging
Ortega-Molina, A., & Serrano, M. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.002 · Cited by 202
“The latter situation is actually observed in the case of mouse models with deficiencies in mTORC1 activity, either by lack of RAPTOR, S6K1, or combined deficiency in S6K1 and S6K2, which, despite impaired insulin signaling, have a superior insulin sensitivity under high-fat diet, compared to wt mice [15,16,28].”
BackgroundWoo, S.-Y., Kim, D.-H., Jun, C.-B., Kim, Y.-M., Haar, E. V., Lee, S.-I., Hegg, J. W., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704343200 · Cited by 202
Mediobasal Hypothalamic p70 S6 Kinase 1 Modulates the Control of Energy Homeostasis
Blouet, C., Ono, H., & Schwartz, G. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.004 · Cited by 198
Cederroth, C. R., Vinciguerra, M., Gjinovci, A., Kühne, F., Klein, M., Cederroth, M., Caille, D., Suter, M., Neumann, D., James, R. W., et al. (2008) · Diabetes · doi:10.2337/db07-0630 · Cited by 202
“Recent evidence indicates that, in response to insulin, S6K1 phosphorylates IRS1 on two inhibitory serine residues (S636/S639), thus preventing further activation of the phosphatidylinositol 3-kinase/Akt signaling pathway (38,39).”
BackgroundRegulation of autophagy by amino acids and MTOR-dependent signal transduction
Meijer, A. J., Lorin, S., Blommaart, E. F., & Codogno, P. (2015) · Amino Acids · doi:10.1007/s00726-014-1765-4 · Cited by 190
mTOR signaling in stem and progenitor cells
Meng, D., Frank, A. R., & Jewell, J. L. (2018) · Development · doi:10.1242/dev.152595 · Cited by 193
“Activated S6K, anmTORC1 substrate, phosphorylates insulin receptor substrate 1 (IRS1), decreasing its half-life (Harrington et al., 2004; Shah and Hunter, 2006; Shah et al., 2004; Tzatsos and Kandror, 2006; Um et al., 2004).”
BackgroundLeptin signaling and circuits in puberty and fertility
Elias, C. F., & Purohit, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1095-1 · Cited by 188
“In agreement, the activation of mTOR pathway is elevated in the liver and in the skeletal muscle of insulinresistant obese rats maintained on a high-fat diet, whereas absence of a downstream mTOR target, the ribosomal S6 kinase (S6K), protects against diet-induced obesity and enhances insulin sensitivity in mice [183,…”
BackgroundClass IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9491-9502.2005 · Cited by 198
“Alternatively, it is possible that reduced signaling to the mTOR pathway in the p85 mKO p85 / hearts from that in wild-type hearts during the 4 weeks of swim exercise circumvents a negative feedback regulation of IRS-1 (53).”
BackgroundRadiation-induced Akt activation modulates radioresistance in human glioblastoma cells
Li, H.-F., Kim, J.-S., & Waldman, T. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-43 · Cited by 190
“tant roles in IR-induced DNA damage repair [37-39], and mTOR regulates the PI3K-Akt signaling pathway at multiple levels [40-43].”
BackgroundmTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Ardestani, A., Lupse, B., Kido, Y., Leibowitz, G., & Maedler, K. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.004 · Cited by 190
“Consequently, the mTORC1 pathway is highly activated in obese individuals and in rodent models of obesity (Cota, 2009; Khamzina et al., 2005; Kucejova et al., 2016; Tremblay et al., 2007; Tsai et al., 2016; Um et al., 2004; Woods et al., 2008).”
BackgroundInfluentialIrs1 Serine 307 Promotes Insulin Sensitivity in Mice
Copps, K. D., Hancer, N. J., Opare-Ado, L., Qiu, W., Walsh, C., & White, M. F. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.003 · Cited by 196
“Mutation of Ser307 Fails to Block HFD-Induced Desensitization of Insulin Signaling Consistent with published data (Um et al., 2004), HFD increased both basal and insulin-stimulated Ser307 phosphorylation in muscle of +/+ and A/+ mice (Figure 3A).”
InfluentialActivation of mTORC1 is essential for β-adrenergic stimulation of adipose browning
Liu, D., Bordicchia, M., Zhang, C., Fang, H., Wei, W., Li, J.-L., Guilherme, A., Guntur, K., Czech, M. P., & Collins, S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83532 · Cited by 193
Vogt, M. C., & Brüning, J. C. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.004 · Cited by 191
Expression and function of the insulin receptor substrate proteins in cancer
Mardilovich, K., Pankratz, S. L., & Shaw, L. M. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-14 · Cited by 192
“Negative feedback regulation of the IRS proteins by serine phosphorylation was first demonstrated in insulin-dependent signaling, and this feedback pathway is essential for regulating insulin sensitivity and glucose homeostasis by limiting the magnitude and duration of the insulin signaling response [49,127-129].”
Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
Menon, S., Yecies, J. L., Zhang, H. H., Howell, J. J., Nicholatos, J., Harputlugil, E., Bronson, R. T., Kwiatkowski, D. J., & Manning, B. D. (2012) · Science Signaling · doi:10.1126/scisignal.2002739 · Cited by 182
“Here, we explore the potential role of the mammalian target of rapamycin (mTOR; also referred to as mechanistic target of rapamycin), which as part of mTOR complex 1 (mTORC1) is a key nutrient-sensing kinase that is aberrantly activated in the liver and other tissues under conditions of obesity (17, 18).”
BackgroundComplexity of the TOR signaling network
Inoki, K., & Guan, K.-L. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.02.002 · Cited by 194
Weickert, M. O., Roden, M., Isken, F., Hoffmann, D., Nowotny, P., Osterhoff, M., Blaut, M., Alpert, C., Gögebakan, Ö., Bumke-Vogt, C., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004374 · Cited by 190
“A rapid onset of insulin resistance in humans exposed to amino acid infusions was reported recently (44, 45), with inhibition of glucose uptake being driven through phosphorylation of downstream factors of the insulin signaling cascade by S6K1 (11, 45), whereas S6K1 knockout mice are protected against diet-induced ins…”
BackgroundArencibia, J. M., Pastor-Flores, D., Bauer, A. F., Schulze, J. O., & Biondi, R. M. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.010 · Cited by 183
Aguilar, V., Alliouachene, S., Sotiropoulos, A., Sobering, A., Athea, Y., Djouadi, F., Miraux, S., Thiaudière, E., Foretz, M., Viollet, B., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.006 · Cited by 183
Chakrabarti, P., Kim, J. Y., Singh, M., Shin, Y.-K., Kim, J., Kumbrink, J., Wu, Y., Lee, M.-J., Kirsch, K. H., Fried, S. K., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01584-12 · Cited by 175
“As reported earlier (52), the activity of mTORC1 in the fat tissues of these animals is increased (Fig.”
BackgroundNew modes of translational control in development, behavior, and disease.
Sonenberg, N., & Hinnebusch, A. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.018 · Cited by 187
“Molecular Cell 28, December 14, 2007 a2007 Elsevier Inc. 725 insulin sensitivity ( Um et al., 2004 ).”
BackgroundBiphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice
Shigeyama, Y., Kobayashi, T., Kido, Y., Hashimoto, N., Asahara, S.-I., Matsuda, T., Takeda, A., Inoue, T., Shibutani, Y., Koyanagi, M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01695-07 · Cited by 177
“Nevertheless, we and others (29) have shown that mTORC1 activity is increased in mice fed a high-fat diet and in db/db mice; thus, mTOR activation in islets may explain the reduced -cell number and increased -cell size associated with type 2 diabetes.”
BackgroundShah, O. J., & Hunter, T. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-05 · Cited by 178
Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats
Ono, H., Pocai, A., Wang, Y., Sakoda, H., Asano, T., Backer, J. M., Schwartz, G. J., & Rossetti, L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34277 · Cited by 175
Brachmann, S. M., Ueki, K., Engelman, J. A., Kahn, R. C., & Cantley, L. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1596-1607.2005 · Cited by 179
“Furthermore, a recent study has shown that deletion of p70 in the mouse increases insulin sensitivity (44).”
BackgroundThe neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
Ham, D. J., Börsch, A., Lin, S., Thürkauf, M., Weihrauch, M., Reinhard, J. R., Delezie, J., Battilana, F., Wang, X., Kaiser, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18140-1 · Cited by 180
mTOR pathway as a target in tissue hypertrophy
Lee, C.-H., Inoki, K., & Guan, K.-L. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105359 · Cited by 179
Regulation and Function of Protein Kinases and Phosphatases
Cheng, H.-C., Qi, R. Z., Paudel, H., & Zhu, H.-J. (2011) · Enzyme Research · doi:10.4061/2011/794089 · Cited by 168
The Integrative Role of CNS Fuel-Sensing Mechanisms in Energy Balance and Glucose Regulation
Sandoval, D., Cota, D., & Seeley, R. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.120806.095256 · Cited by 178
Regulatory circuits controlling white versus brown adipocyte differentiation
Hansen, J. B., & Kristiansen, K. (2006) · Biochemical Journal · doi:10.1042/bj20060402 · Cited by 178
Wang, C.-Y., Kim, H.-H., Hiroi, Y., Sawada, N., Salomone, S., Benjamin, L. E., Walsh, K., Moskowitz, M. A., & Liao, J. K. (2009) · Science Signaling · doi:10.1126/scisignal.2000143 · Cited by 177
“Although mTOR signaling in the hypothalamus regulates food intake (10) and absence of S6 K enhances insulin sensitivity and protects against diet- and age-related obesity (12), our findings in Akt1 null mice fed a highfat diet suggest that Akt, rather than mTOR, is the critical mediator of vascular senescence because…”
BackgroundZhao, X., Han, Q., Liu, Y., Sun, C., Gang, X., & Wang, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2794591 · Cited by 174
“Studies have shown that persistent high nutrient signaling might lead to the onset of IR mediated by mTORC1 signaling pathway [16, 46].”
BackgroundActivated FOXO-mediated insulin resistance is blocked by reduction of TOR activity
Luong, N., Davies, C. R., Wessells, R. J., Graham, S. M., King, M. T., Veech, R., Bodmer, R., & Oldham, S. M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.013 · Cited by 174
Gan, X., Wang, J., Wang, C., Sommer, E., Kozasa, T., Srinivasula, S., Alessi, D., Offermanns, S., Simon, M. I., & Wu, D. (2012) · Nature Cell Biology · doi:10.1038/ncb2507 · Cited by 163
Kolb, E. A., Gorlick, R., Houghton, P. J., Morton, C. L., Lock, R., Carol, H., Reynolds, C. P., Maris, J. M., Keir, S. T., Billups, C. A., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21450 · Cited by 175
mTORC1 signaling in hepatic lipid metabolism
Han, J., & Wang, Y. (2018) · Protein & Cell · doi:10.1007/s13238-017-0409-3 · Cited by 170
“…signaling, and impaired lipid metabolism in the liver affect each other and may further exacerbate vulnerable lipid homeostasis and insulin sensitivity in obesity (Um et al., 2004; Khamzina et al., 2005; Yang et al., 2010; Samuel and Shulman, 2012; Han et al., 2015; Martinez-Lopez and Singh, 2015).”
BackgroundInfluentialRole of Rho-kinase in regulation of insulin action and glucose homeostasis
Furukawa, N., Ongusaha, P., Jahng, W. J., Araki, K., Choi, C. S., Kim, H.-J., Lee, Y. H., Kaibuchi, K., Kahn, B. B., Masuzaki, H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.011 · Cited by 172
mTOR signaling: implications for cancer and anticancer therapy
Petroulakis, E., Mamane, Y., Le Bacquer, O., Shahbazian, D., & Sonenberg, N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602902 · Cited by 170
“Also, deletion of S6K1 in mice renders them resistant to age- and high-fat diet-induced obesity while enhancing insulin sensitivity (Um et al, 2004).”
BackgroundActivation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo
Wu, Y., Song, P., Zhang, W., Liu, J., Dai, X., Liu, Z., Lu, Q., Ouyang, C., Xie, Z., Zhao, Z., et al. (2015) · Nature Medicine · doi:10.1038/nm.3826 · Cited by 169
Insulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 164
“Mice deficient for S6K1 are hyperglycemic due to reduced insulin secretion, but are small and have reduced fatty acid levels associated with increased β-oxidation in adipose tissue (Pende et al., 2000; Um et al., 2004).”
BackgroundConverging Pathways in Lifespan Regulation
Narasimhan, S. D., Yen, K., & Tissenbaum, H. A. (2009) · Current Biology · doi:10.1016/j.cub.2009.06.013 · Cited by 168
“Further, S6K knockout mice are resistant to diet-induced obesity and age-related obesity [59].”
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition
Han, E. K.-H., Leverson, J. D., McGonigal, T., Shah, O. J., Woods, K. W., Hunter, T., Giranda, V. L., & Luo, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210343 · Cited by 168
“This feedback activity is sufficient to dampen insulin- and IGF-I-induced Akt signaling both in response to prolonged insulin treatment and in tumor models in which the mTORC1/S6K1 axis is constitutively engaged (Harrington et al., 2004; Shah et al., 2004; Um et al., 2004).”
BackgroundThe mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration
Yang, L., Miao, L., Liang, F., Huang, H., Teng, X., Li, S., Nuriddinov, J., Selzer, M. E., & Hu, Y. (2014) · Nature Communications · doi:10.1038/ncomms6416 · Cited by 157
Autophagy in tumor suppression and cancer therapy
Kung, C.-P., Budina, A., Balaburski, G., Bergenstock, M. K., & Murphy, M. (2011) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i1.50 · Cited by 166
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.